These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
269 related items for PubMed ID: 1638577
1. Fluoroquinolone antibiotics: properties of the class and individual agents. Stratton C. Clin Ther; 1992; 14(3):348-75; discussion 347. PubMed ID: 1638577 [Abstract] [Full Text] [Related]
2. Lomefloxacin and temafloxacin: two new fluoroquinolone antimicrobials. Symonds WT, Nix DE. Clin Pharm; 1992 Sep; 11(9):753-66. PubMed ID: 1325892 [Abstract] [Full Text] [Related]
3. The role of the fluoroquinolones. Guay DR. Pharmacotherapy; 1992 Sep; 12(6 Pt 2):71S-85S. PubMed ID: 1480503 [Abstract] [Full Text] [Related]
4. The place of quinolones in bacterial infections. Neu HC. Adv Intern Med; 1991 Sep; 36():1-32. PubMed ID: 2024577 [Abstract] [Full Text] [Related]
5. Enoxacin: a new fluoroquinolone. Jaber LA, Bailey EM, Rybak MJ. Clin Pharm; 1989 Feb; 8(2):97-107. PubMed ID: 2645085 [Abstract] [Full Text] [Related]
6. Overview of the fluoroquinolone antibiotics. Just PM. Pharmacotherapy; 1993 Feb; 13(2 Pt 2):4S-17S. PubMed ID: 8386356 [Abstract] [Full Text] [Related]
7. Rufloxacin (MF-934): in vitro and in vivo antibacterial activity. Ravizzola G, Pinsi G, Pirali F, Colombrita D, Foresti I, Peroni L, Turano A. Drugs Exp Clin Res; 1989 Feb; 15(1):11-5. PubMed ID: 2743869 [Abstract] [Full Text] [Related]
8. Do we need an intravenous fluoroquinolone? Maddix DS, Warner L. West J Med; 1992 Jul; 157(1):55-9. PubMed ID: 1413744 [Abstract] [Full Text] [Related]
9. Fluoroquinolones: how to use (but not overuse) these antibiotics. Sable CA, Scheld WM. Geriatrics; 1993 Jun; 48(6):41-4, 49-51. PubMed ID: 8500773 [Abstract] [Full Text] [Related]
10. Quinolones: a comprehensive review. Oliphant CM, Green GM. Am Fam Physician; 2002 Feb 01; 65(3):455-64. PubMed ID: 11858629 [Abstract] [Full Text] [Related]
11. Temafloxacin: an overview. Pankey GA. Am J Med; 1991 Dec 30; 91(6A):166S-172S. PubMed ID: 1662889 [Abstract] [Full Text] [Related]
14. The fluoroquinolones for urinary tract infections: a review. Cunha BA. Adv Ther; 1994 Sep 30; 11(6):277-96. PubMed ID: 10150268 [Abstract] [Full Text] [Related]
15. [In vitro evaluation of lomefloxacin]. Dette GA, Knothe H. Arzneimittelforschung; 1989 Aug 30; 39(8):832-5. PubMed ID: 2818672 [Abstract] [Full Text] [Related]
16. Ciprofloxacin: an update on clinical experience. Arcieri G, Griffith E, Gruenwaldt G, Heyd A, O'Brien B, Becker N, August R. Am J Med; 1987 Apr 27; 82(4A):381-6. PubMed ID: 3555063 [Abstract] [Full Text] [Related]
17. Ciprofloxacin: an oral quinolone for the treatment of infections with gram-negative pathogens. Committee on Antimicrobial Agents. Canadian Infectious Disease Society. Louie TJ. CMAJ; 1994 Mar 01; 150(5):669-76. PubMed ID: 8313286 [Abstract] [Full Text] [Related]
18. Use of fluoroquinolones: practical considerations. Ponte CD, Fisher MA. Am Fam Physician; 1993 Apr 01; 47(5):1243-9. PubMed ID: 8465719 [Abstract] [Full Text] [Related]
19. A risk-benefit assessment of levofloxacin in respiratory, skin and skin structure, and urinary tract infections. Martin SJ, Jung R, Garvin CG. Drug Saf; 2001 Apr 01; 24(3):199-222. PubMed ID: 11347723 [Abstract] [Full Text] [Related]
20. Levofloxacin, a second-generation fluoroquinolone. North DS, Fish DN, Redington JJ. Pharmacotherapy; 1998 Apr 01; 18(5):915-35. PubMed ID: 9758306 [Abstract] [Full Text] [Related] Page: [Next] [New Search]